Perspectives International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation
نویسندگان
چکیده
Michele Cavo,1 S. Vincent Rajkumar,2 Antonio Palumbo,3 Philippe Moreau,4 Robert Orlowski,5 Joan Bladé,6 Orhan Sezer,7 Heinz Ludwig,8 Meletios A. Dimopoulos,9 Michel Attal,10 Pieter Sonneveld,11 Mario Boccadoro,12 Kenneth C. Anderson,13 Paul G. Richardson,13 William Bensinger,14 Hans E. Johnsen,15 Nicolaus Kroeger,16 Gösta Gahrton,17 P. Leif Bergsagel,18 David H. Vesole,19 Hermann Einsele,20 Sundar Jagannath,21 Ruben Niesvizky,22 Brian G. M. Durie,23 Jesus San Miguel,24 and Sagar Lonial,25 on behalf of the International Myeloma Working Group
منابع مشابه
Plerixafor in the Treatment of Stem Cell Mobilization Failure; First Experience in Iran
High-dose chemotherapy and autologous stem cell transplantation (SCT) have become an effective care for many patients with hematological malignancies. Harvesting the stem cells is one the most important parts of SCT. The two most commonly used mobilization regimens are the use of granulocyte colony-stimulating factor (G-CSF) or G-CSF plus chemotherapy. However, about 10-30% of patients are unab...
متن کاملPlerixafor in the Treatment of Stem Cell Mobilization Failure; First Experience in Iran
High-dose chemotherapy and autologous stem cell transplantation (SCT) have become an effective care for many patients with hematological malignancies. Harvesting the stem cells is one the most important parts of SCT. The two most commonly used mobilization regimens are the use of granulocyte colony-stimulating factor (G-CSF) or G-CSF plus chemotherapy. However, about 10-30% of patients are unab...
متن کاملInternational Myeloma Working Group (imwg) Consensus Approach to the Treatment of Multiple Myeloma Patients Who Are Candidates for Autologous Stem-cell Transplantation
310For personal use only.on April 5, 2017.by guestwww.bloodjournal.orgFrom
متن کاملInternational Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.
The role of high-dose therapy followed by autologous stem cell transplantation (ASCT) in the treatment of multiple myeloma (MM) continues to evolve in the novel agent era. The choice of induction therapy has moved from conventional chemotherapy to newer regimens incorporating the immunomodulatory derivatives thalidomide or lenalidomide and the proteasome inhibitor bortezomib. These drugs combin...
متن کاملRelation between Age, Gender, Number of Blood Products Received and Diagnosis with Engraftment and Length of Hospital Stay in Patients Undergoing Autologous Stem Cell Transplantation
Background and purpose: Autologous hematopoietic stem cell transplantation may be one of the best treatment options for some patients with hematological malignancies. The process of stem cell homing in the bone marrow and the production and proliferation of denovo cell populations is called engraftment and could be considered as one of the key factors in the success of stem cell transplantation...
متن کامل